Correlation Between Arcus Biosciences and 23Andme Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and 23Andme Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and 23Andme Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and 23Andme Holding Co, you can compare the effects of market volatilities on Arcus Biosciences and 23Andme Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of 23Andme Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and 23Andme Holding.

Diversification Opportunities for Arcus Biosciences and 23Andme Holding

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Arcus and 23Andme is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and 23Andme Holding Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 23Andme Holding and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with 23Andme Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 23Andme Holding has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and 23Andme Holding go up and down completely randomly.

Pair Corralation between Arcus Biosciences and 23Andme Holding

Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.64 times more return on investment than 23Andme Holding. However, Arcus Biosciences is 1.57 times less risky than 23Andme Holding. It trades about 0.14 of its potential returns per unit of risk. 23Andme Holding Co is currently generating about -0.01 per unit of risk. If you would invest  1,456  in Arcus Biosciences on September 25, 2024 and sell it today you would earn a total of  135.00  from holding Arcus Biosciences or generate 9.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Arcus Biosciences  vs.  23Andme Holding Co

 Performance 
       Timeline  
Arcus Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Arcus Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Arcus Biosciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Arcus Biosciences and 23Andme Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcus Biosciences and 23Andme Holding

The main advantage of trading using opposite Arcus Biosciences and 23Andme Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, 23Andme Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 23Andme Holding will offset losses from the drop in 23Andme Holding's long position.
The idea behind Arcus Biosciences and 23Andme Holding Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon